V-69
Disorders of the Nervous System
Why Some Neurons Die First: Uncovering the Regulatory Programs of Selective Neuronal Vulnerability
Camila D. Arcuschin1,2, Alexia Lantheaume3, Saeede Salehi3, Abdolhossein Zare3, M. Pilar Leguiza1,2, Pedro Salaberry2,4, Marina Pinkasz1,2, Martín Iungman1,2, Michael Briese3, Philip Tovote3, María Soledad Espósito5, Ignacio E. Schor2,4
1. Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales.
2. CONICET-Universidad de Buenos Aires, Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE), Buenos Aires, Argentina.
3. Julius-Maximilians-Universität of Würzburg , Würzburg, Germany.
4. Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales. Departamento de Fisiología, Biología Molecular y Celular.
5. Departamento de Investigación Traslacional, Comisión Nacional de Energía Atómica, Centro Atomico Bariloche , Río Negro, Argentina.
Presenting Author:
arcucamila@gmail.com
Synucleinopathies are a group of disorders, including Parkinson's disease, characterized by the formation of α-synuclein (αSyn) aggregates and neurodegeneration in specific brain regions. However, the molecular mechanisms underlying the differential neuronal susceptibility, known as selective vulnerability, remain poorly understood. To investigate these mechanisms, we used a mouse model of synucleinopathy that drives pathogenic αSyn overexpression in neuronal populations of the substantia nigra and locus coeruleus, two regions that exhibit distinct temporal patterns of vulnerability. Single-nucleus RNA sequencing, combined with a gene regulatory network reconstructed from public datasets, recovered associations between neuronal vulnerability and gene expression regulators with established roles in neurodegeneration, as well as newly identified candidates not previously linked to this process. In particular, we uncovered a set of 26 regulators that displayed changes in activity in both dopaminergic and noradrenergic neurons that closely paralleled their distinct neurodegeneration kinetics. Neurodegeneration-associated changes in the activity of this set of regulators were further validated using data from human cells and Parkinson's disease patients. Finally, we show evidence suggesting that intrinsic differences in the basal expression of neuroprotective regulatory genes may contribute to the differential responses of these neuronal populations to αSyn pathology.